R&D Cell therapy transportation and storage with hydrogels Hydrogels are revolutionising cell therapy storage – discover how they tackle cold chain challenges and reduce costs while preserving cell viability.
Partner Content Partner Content Highly Anticipated Attendee List Released for Cold Chain Dis... Cold Chain 2017
Partner Content Partner Content Opposites Attract: Organisational Culture and Supply Chain P... Cold Chain Distribution 2017
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.